Beam Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	49,558	49,253	41,131	36,504	52,503	109,210
Market Cap Growth	6.23%	19.75%	12.67%	-30.47%	-51.92%	19.04%
Enterprise Value	30,580	32,626	25,217	22,278	34,634	93,056
Last Close Price	520.00	485.00	531.00	750.00	-	-
PS Ratio	19.70	19.58	31.08	5.72	44.18	102.75
PB Ratio	2.22	2.21	2.69	2.20	3.67	6.44
P/TBV Ratio	2.22	2.21	2.69	2.20	3.67	6.44
P/OCF Ratio	-	-	-	-	119.48	-
EV/Sales Ratio	12.58	12.97	19.05	3.49	29.15	87.56
Debt / Equity Ratio	0.12	0.12	0.22	0.18	0.25	0.18
Net Debt / Equity Ratio	-0.88	-0.88	-0.94	-1.04	-1.22	-0.99
Net Debt / EBITDA Ratio	3.02	3.02	1.75	6.50	2.77	3.56
Net Debt / FCF Ratio	3.03	3.03	1.94	5.56	33.96	7.23
Asset Turnover	0.11	0.11	0.05	0.27	0.04	0.05
Quick Ratio	12.85	12.85	4.67	5.79	4.82	5.93
Current Ratio	13.09	13.09	4.82	5.89	4.89	5.96
Return on Equity (ROE)	-8.11%	-8.11%	-43.94%	-15.46%	-37.06%	-69.13%
Return on Assets (ROA)	-18.55%	-18.55%	-20.26%	-7.88%	-15.02%	-15.41%
Return on Capital Employed (ROCE)	-27.70%	-27.70%	-45.10%	-14.10%	-30.30%	-18.80%
Earnings Yield	-2.91%	-2.92%	-19.09%	-6.14%	-10.74%	-6.96%
FCF Yield	-13.08%	-13.16%	-18.05%	-8.47%	-0.98%	-2.12%
Buyback Yield / Dilution	-20.16%	-20.16%	-6.69%	-10.19%	-9.01%	-37.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.